Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-12-12

Clinical Trial Update: Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus Placebo [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating TL01 in combination with tacrolimus ointment versus placebo for vitiligo has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TL01
  • Tacrolimus ointment (tacrolimus)

Snippet

Sponsor: Oslo University Hospital | Conditions: Vitiligo | Phase 3 | Status: COMPLETED